WBP2 and breast cancer: A Wnt pathway crosstalk is substantial in breast cancer; for example, in the Hippo pathway, a transcriptional coactivator called WW domain binding protein 2 (WBP2) forms a network with YAP, TAZ, and β-catenin, which then promotes TCF-induced malignancy [136].